Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_provenance.
- NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_assertion description "[Furthermore, in the haplotype analysis of IL-10 gene, we found that patients carrying ATA haplotype were in higher LN involvement (p = 0.022) and higher tumor stage(p = 0.028) of breast cancer at the time of diagnosis compared with others.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_provenance.
- NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_assertion evidence source_evidence_literature NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_provenance.
- NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_assertion SIO_000772 20553628 NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_provenance.
- NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_assertion wasDerivedFrom befree-2016 NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_provenance.
- NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_assertion wasGeneratedBy ECO_0000203 NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_provenance.
- befree-2016 importedOn "2016-02-19" NP819283.RApCjJVXUa2TrM-206TWQME_0r1qgM-AlyZbTgMazfTEo130_provenance.